发明名称 |
EXTRACELLULAR TARGETED DRUG CONJUGATES |
摘要 |
Extracellular drug conjugates (EDCs) targeting an extracellular protein or portion thereof (e.g., CD38) and comprising a non-cleavable linker including one or two nitrogen heteroatoms are useful in the treatment of diseases such as cancer and immune disorders, including asthma. |
申请公布号 |
US2017049908(A1) |
申请公布日期 |
2017.02.23 |
申请号 |
US201615239506 |
申请日期 |
2016.08.17 |
申请人 |
CENTROSE, LLC |
发明人 |
Prudent James R. |
分类号 |
A61K47/48;A61K31/585;A61K31/56;C07K16/28;A61K31/7048 |
主分类号 |
A61K47/48 |
代理机构 |
|
代理人 |
|
主权项 |
1. An extracellular-targeted drug conjugate (EDC) comprising a targeting moiety linked by a stable or non-cleavable linker to an agent, wherein the targeting moiety binds to an extracellular protein or fragment thereof, wherein the agent binds to or modifies the activity of a Na,K-ATPase, and wherein the non-cleavable linker includes one or two nitrogen heteroatoms. |
地址 |
Madison WI US |